Skip to main content
OpenTrials
Completed

NCT Number: NCT06610045

The Burden of Multiple Myeloma on Patients and Caregivers Quality of Life: a Canadian Real-World Study

The purpose of this observational study is to estimate the burden of multiple myeloma on patients and caregivers in terms of QoL. Additionally, this study will assess the correlation between QoL, obtained from commonly used and validated questionnaires, and the perceptions of both patients and caregivers respectively., obtain from a 10-point scale and a comment box.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Potential participants will be identified by Myeloma Canada using their database. Myeloma Canada is a registered non-profit organization created by, and for, Canadians impacted by multiple myeloma. As part of Myeloma Canada website, patients and caregivers can subscribe to a mailing list to receive their monthly newsletter and to participate in surveys. This database comprises about 5,000 individuals, including patients and caregivers.

An e-mail will be sent to 600 patients and 200 caregivers randomly selected to invited them to participate in the survey. Interested participants will be invited to visit the Participant Portal on the PROxy website (https://periproxy.com/en), to sign the informed consent form and complete online questionnaires. Upon request, paper-based documents (i.e., informed consent form and questionnaires) can also be sent by mail. The following questionnaires will be used:

Patients

  • Patient Information Questionnaire (i.e., baseline characteristics)
  • EORTC QLQ-C30
  • EORTC QLQ-MY20
  • EQ-5D-5L
  • ESAS-R
  • Patients Perspective

Caregivers

  • Caregiver Information Questionnaire (i.e., baseline characteristics)
  • CarGOQoL
  • Caregivers Perspective

If the sample size (i.e., 300 patients and 100 caregivers) is not reached one month after the first e-mail, an invitation e-mail will be sent to an additional 600 eligible patients and/or 200 caregivers randomly selected. This scheme of participant identification will be performed until the sample size is reached.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older;
  • Part of the Myeloma Canada database;
  • Identified as a patient with MM or
  • Identified as a current caregiver of a patient with MM at the time of participation.
  • Ability to read and understand English or French;
  • Signature of informed consent form (ICF).

Exclusion criteria

No exclusion criteria

Treatment and study plan

No intervention

Other

No specific intervention is assess in this study.

Primary outcomes

  1. To estimate quality of life of patients with myeloma and caregivers of patients with myeloma

    Time frame: From enrollment until sample size is reached

Secondary outcomes

  1. To assess the correlation between QoL scores and perception of patients and caregivers respectively

    Time frame: From recruitment until sample size is reached

Sponsors and collaborators

Lead sponsor

PeriPharm

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Sep 24, 2024
Registry last updated
Mar 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.